Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  American Journal of Clinical Pathology

• Publication date

  2003-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1309/2E6Q-GJRG-GETV-T8K9PMID 12931546
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• On non-parametric statistical methods

  2005cited by this paper
• Encapsulated follicular variant of papillary thyroid carcinoma.

  2002cited by this paper
• Encapsulated follicular variant of papillary thyroid carcinoma.

  2002cited by this paper
• Follicular-patterned lesions of the thyroid: the bane of the pathologist.

  2002cited by this paper
• Diagnosis of “follicular neoplasm”: A gray zone in thyroid fine‐needle aspiration cytology

  2002cited by this paper
• Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions.

  2002cited by this paper
• Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.

  2002cited by this paper
• Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.

  2002cited by this paper
• Cytokeratin 19 and galectin‐3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules

  2002cited by this paper
• PAX8-PPAR&ggr; Rearrangement in Thyroid Tumors: RT-PCR and Immunohistochemical Analyses

  2002cited by this paper
• Expression of PAX8-PPARγ1 Rearrangements in Both Follicular Thyroid Carcinomas and Adenomas

  2002cited by this paper
• Immunohistochemical Diagnosis of Papillary Thyroid Carcinoma

  2001cited by this paper
• Variable expression of keratins and nearly uniform lack of thyroid transcription factor 1 in thyroid anaplastic carcinoma.

  2000cited by this paper
• Follicular lesions of the thyroid. W(h)ither follicular carcinoma?

  2000cited by this paper
• PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].

  2000cited by this paper
• PAX8-PPARγ1 Fusion in Oncogene Human Thyroid Carcinoma

  2000cited by this paper
• Follicular Lesions of the Thyroid W(h)ither Follicular Carcinoma

  2000cited by this paper
• Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility.

  1999cited by this paper
• Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules.

  1999cited by this paper
• Expression of galectin‐3 in fine‐needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms

  1999cited by this paper
• Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours

  1996cited by this paper
• Permutation Tests: A Practical Guide to Resampling Methods for Testing Hypotheses

  1995cited by this paper
• The Demise of Follicular Carcinoma of the Thyroid Gland

  1994cited by this paper
• Surgical Pathology of the Thyroid

  1993cited by this paper
• Atlas of tumor pathology. Third series

  1991cited by this paper
• Non-parametric Statistical Methods

  1990cited by this paper
• Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.

  1988cited by this paper
• Cytopathology of follicular lesions of the thyroid gland

  1985cited by this paper
• Expression of intermediate filament proteins in thyroid gland and thyroid tumors.

  1984cited by this paper
• Tumors of the thyroid gland.

  1950cited by this paper

• FAM172A promotes follicular thyroid carcinogenesis and may be a marker of FTC

  2020cites this paper
• PPAR-γ Agonists and Their Role in Primary Cicatricial Alopecia

  2017cites this paper
• APLP2, RRM2, and PRC1: New Putative Markers for the Differential Diagnosis of Thyroid Follicular Lesions

  2017cites this paper
• Most Thyroid Cancers Detected by Sonography Lack Intranodular Vascularity on Color Doppler Imaging: Review of the Literature and Sonographic‐Pathologic Correlations for 698 Thyroid Neoplasms

  2017cites this paper
• Pathology of Follicular Cancer

  2016cites this paper
• Proteomics in thyroid cytopathology: Relevance of MALDI‐imaging in distinguishing malignant from benign lesions

  2016cites this paper
• Thyroid, Parathyroid and Adrenal Glands

  2015cites this paper
• Modeling follicular thyroid cancer for future therapies.

  2012cites this paper
• Review Article Modeling follicular thyroid cancer for future therapies

  2012cites this paper
• Thyroid and Parathyroid Gland

  2011cites this paper
• Thyroid Cancer: Current Molecular Perspectives

  2010cites this paper
• Molecular aspects of thyroid hormone actions.

  2010cites this paper
• Application of immunohistochemistry to thyroid neoplasms.

  2009cites this paper
• The Role of the PAX8/PPARγ Fusion Oncogene in Thyroid Cancer

  2008cites this paper
• Follicular neoplasm of the thyroid—vanishing cytologic diagnosis?

  2007cites this paper
• Thyroid hormone receptor mutations and disease: insights from knock-in mouse models

  2007cites this paper
• Our approach to follicular-patterned lesions of the thyroid

  2006cites this paper
• PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway.

  2006cites this paper
• Treatment of thyroid cancer with histone deacetylase inhibitors and peroxisome proliferator-activated receptor-gamma agonists.

  2005cites this paper
• Evaluation of Peroxisome Proliferator-Activated Receptor-γ Expression in Benign and Malignant Thyroid Pathologies

  2005cites this paper
• The role of immunohistochemical markers in the diagnosis of follicular-patterned lesions of the thyroid

  2005cites this paper
• Peroxisome proliferator‐activated receptors in squamous cell carcinoma and its precursors

  2005cites this paper
• Understanding the genotype of follicular thyroid tumors

  2005cites this paper
• Treatment of Thyroid Cancer with Histone Deacetylase Inhibitors and Peroxisome Proliferator-Activated Receptor–γ Agonists

  2005cites this paper
• Role of Immunohistochemistry in the Diagnosis and Progression of Follicular Epithelium-Derived Thyroid Carcinoma

  2005cites this paper
• Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance.

  2005cites this paper
• Follicular Neoplasms of the Thyroid: View, Biases, and Experiences

  2004cites this paper
• Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.

  2004cites this paper
• PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.

  2004cites this paper
• Review Article Peroxisome Proliferator-activated Receptor-í Μí»¾ in Thyroid Autoimmunity

  year unknowncites this paper